{"transactions":[{"id":1693924,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-03T21:25:31.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":148,"price":84.12,"value":12449.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are full vested from the moment of grant. Shares issued at per share price of $84.12, representing the Issuer's closing stock price on January 2, 2024."}],"balance_after":18801,"source":{"system":"sec-edgar","filing":"0001127602-24-000429","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760224000429/form4.xml","form_type":"4"}},{"id":1768487,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-03T20:16:35.000Z","date":"2023-10-02","kind":"grant","planned":false,"acquired":true,"shares":448,"price":27.88,"value":12490.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $27.88, representing the Issuer's closing stock price on October 2, 2023."}],"balance_after":18653,"source":{"system":"sec-edgar","filing":"0001127602-23-025174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223025174/form4.xml","form_type":"4"}},{"id":1837389,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-05T20:23:14.000Z","date":"2023-07-03","kind":"grant","planned":false,"acquired":true,"shares":374,"price":33.36,"value":12476.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $33.36, representing the Issuer's closing stock price on July 3, 2023."}],"balance_after":18205,"source":{"system":"sec-edgar","filing":"0001127602-23-020059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223020059/form4.xml","form_type":"4"}},{"id":1887374,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2023-05-18T21:18:29.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2023 and the last such installment vesting on 05/10/2024."}],"balance_after":10000,"derivative":{"exercise_price":37.89,"exercise_date":"2023-06-10","expiration_date":"2033-05-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001127602-23-016208","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223016208/form4.xml","form_type":"4"}},{"id":1887373,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-18T21:18:29.000Z","date":"2023-05-10","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units that will vest in full and in one installment on 05/10/2024."}],"balance_after":17831,"source":{"system":"sec-edgar","filing":"0001127602-23-016208","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223016208/form4.xml","form_type":"4"}},{"id":1925618,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-05T20:06:26.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":298,"price":37.71,"value":11237.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of director's annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $37.71, representing the closing stock price of the Issuer's common stock on April 3, 2023."}],"balance_after":12831,"source":{"system":"sec-edgar","filing":"0001127602-23-012545","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223012545/form4.xml","form_type":"4"}},{"id":2069390,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-04T23:36:34.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":253,"price":44.35,"value":11220.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in leu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $44.35, representing the closing stock price of the Issuer's common stock on January 3, 2023."}],"balance_after":12533,"source":{"system":"sec-edgar","filing":"0001127602-23-000707","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760223000707/form4.xml","form_type":"4"}},{"id":2142689,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-10-05T20:22:45.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":110,"price":51.11,"value":5622.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in leu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares are issued at per share price of $51.11, representing the closing stock price of the Issuer's common stock on October 3, 2022."}],"balance_after":12280,"source":{"system":"sec-edgar","filing":"0001127602-22-023700","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222023700/form4.xml","form_type":"4"}},{"id":2167996,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2022-09-02T22:29:30.000Z","date":"2022-09-02","kind":"exercise","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7500,"derivative":{"exercise_price":37.89,"exercise_date":"2022-06-10","expiration_date":"2032-05-10","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001127602-22-022049","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222022049/form4.xml","form_type":"4"}},{"id":2167995,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2022-09-02T22:29:30.000Z","date":"2022-09-02","kind":"exercise","acquired":false,"shares":5834,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":24.32,"exercise_date":"2021-06-12","expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":5834},"source":{"system":"sec-edgar","filing":"0001127602-22-022049","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222022049/form4.xml","form_type":"4"}},{"id":2167994,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Non-Qualified Stock Option (Right to Buy)","published_at":"2022-09-02T22:29:30.000Z","date":"2022-09-02","kind":"exercise","acquired":false,"shares":3035,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":10.68,"exercise_date":"2019-06-15","expiration_date":"2029-05-15","underlying":"Common Stock","underlying_shares":3035},"source":{"system":"sec-edgar","filing":"0001127602-22-022049","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222022049/form4.xml","form_type":"4"}},{"id":2167993,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-09-02T22:29:30.000Z","date":"2022-09-02","kind":"sale","acquired":false,"shares":11369,"price":53.97,"value":613584.93,"ownership":{"direct":true},"balance_after":12170,"source":{"system":"sec-edgar","filing":"0001127602-22-022049","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222022049/form4.xml","form_type":"4"}},{"id":2167992,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-09-02T22:29:30.000Z","date":"2022-09-02","kind":"exercise","acquired":true,"shares":2500,"price":37.89,"value":94725.0,"ownership":{"direct":true},"balance_after":23539,"source":{"system":"sec-edgar","filing":"0001127602-22-022049","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222022049/form4.xml","form_type":"4"}},{"id":2167991,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-09-02T22:29:30.000Z","date":"2022-09-02","kind":"exercise","acquired":true,"shares":5834,"price":24.32,"value":141882.88,"ownership":{"direct":true},"balance_after":21039,"source":{"system":"sec-edgar","filing":"0001127602-22-022049","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222022049/form4.xml","form_type":"4"}},{"id":2167990,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-09-02T22:29:30.000Z","date":"2022-09-02","kind":"exercise","acquired":true,"shares":3035,"price":10.68,"value":32413.8,"ownership":{"direct":true},"balance_after":15205,"source":{"system":"sec-edgar","filing":"0001127602-22-022049","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222022049/form4.xml","form_type":"4"}},{"id":2208737,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-07-12T20:32:27.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":137,"price":41,"value":5617.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Share are fully vested from the moment of grant. Shares are issued at per share price of $41.00, representing the closing stock price of the Issuer's common stock on July 1, 2022."}],"balance_after":12170,"source":{"system":"sec-edgar","filing":"0001127602-22-019239","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000112760222019239/form4.xml","form_type":"4"}},{"id":2275151,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-05-11T22:06:37.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/10/2022 and the last such installment vesting on 05/10/2023."}],"balance_after":10000,"derivative":{"exercise_price":37.89,"expiration_date":"2032-05-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001061983-22-000121","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000121/edgardoc.xml","form_type":"4"}},{"id":2275150,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-11T22:06:37.000Z","date":"2022-05-10","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units that will vest in full and in one installment on 05/10/2023."}],"balance_after":12033,"source":{"system":"sec-edgar","filing":"0001061983-22-000121","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000121/edgardoc.xml","form_type":"4"}},{"id":2311675,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-01T23:17:35.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":146,"price":38.38,"value":5603.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are fully vested from the moment of grant. Shares issued at per share price of $38.38, representing the Issuer's closing stock price on April 1, 2022."}],"balance_after":7033,"source":{"system":"sec-edgar","filing":"0001061983-22-000089","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000089/edgardoc.xml","form_type":"4"}},{"id":2450727,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T21:47:46.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":122,"price":46,"value":5612.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. Shares are full vested from the moment of grant. Shares issued at per share price of $46.00, representing the Issuer's closing stock price on January 3, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,887 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6887,"source":{"system":"sec-edgar","filing":"0001061983-22-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198322000012/edgardoc.xml","form_type":"4"}},{"id":2458049,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-12-28T22:16:25.000Z","date":"2021-12-27","kind":"exercise","acquired":false,"shares":4166,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5834,"derivative":{"exercise_price":24.32,"exercise_date":"2021-06-12","expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":4166},"source":{"system":"sec-edgar","filing":"0001061983-21-000268","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000268/edgardoc.xml","form_type":"4"}},{"id":2458048,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-12-28T22:16:25.000Z","date":"2021-12-27","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":21.61,"exercise_date":"2021-05-13","expiration_date":"2030-05-13","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001061983-21-000268","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000268/edgardoc.xml","form_type":"4"}},{"id":2458047,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-12-28T22:16:25.000Z","date":"2021-12-27","kind":"exercise","acquired":false,"shares":4124,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":15.43,"exercise_date":"2020-02-12","expiration_date":"2030-02-12","underlying":"Common Stock","underlying_shares":4124},"source":{"system":"sec-edgar","filing":"0001061983-21-000268","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000268/edgardoc.xml","form_type":"4"}},{"id":2458046,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T22:16:25.000Z","date":"2021-12-27","kind":"sale","acquired":false,"shares":4124,"price":45.79,"value":188837.96,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6765,"source":{"system":"sec-edgar","filing":"0001061983-21-000268","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000268/edgardoc.xml","form_type":"4"}},{"id":2458045,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T22:16:25.000Z","date":"2021-12-27","kind":"exercise","acquired":true,"shares":4124,"price":15.43,"value":63633.32,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":10889,"source":{"system":"sec-edgar","filing":"0001061983-21-000268","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000268/edgardoc.xml","form_type":"4"}},{"id":2458044,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T22:16:25.000Z","date":"2021-12-27","kind":"sale","acquired":false,"shares":20000,"price":45.79,"value":915800.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6765,"source":{"system":"sec-edgar","filing":"0001061983-21-000268","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000268/edgardoc.xml","form_type":"4"}},{"id":2458043,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T22:16:25.000Z","date":"2021-12-27","kind":"exercise","acquired":true,"shares":20000,"price":21.61,"value":432200.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":26765,"source":{"system":"sec-edgar","filing":"0001061983-21-000268","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000268/edgardoc.xml","form_type":"4"}},{"id":2458042,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T22:16:25.000Z","date":"2021-12-27","kind":"sale","acquired":false,"shares":4166,"price":45.79,"value":190761.14,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6765,"source":{"system":"sec-edgar","filing":"0001061983-21-000268","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000268/edgardoc.xml","form_type":"4"}},{"id":2458041,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-28T22:16:25.000Z","date":"2021-12-27","kind":"exercise","acquired":true,"shares":4166,"price":24.32,"value":101317.12,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":10931,"source":{"system":"sec-edgar","filing":"0001061983-21-000268","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000268/edgardoc.xml","form_type":"4"}},{"id":2503410,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-11-19T23:16:36.000Z","date":"2021-11-19","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":14.25,"exercise_date":"2017-06-18","expiration_date":"2027-05-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001061983-21-000261","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000261/edgardoc.xml","form_type":"4"}},{"id":2503409,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-11-19T23:16:36.000Z","date":"2021-11-19","kind":"exercise","acquired":false,"shares":4032,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":12.4,"exercise_date":"2017-02-03","expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":4032},"source":{"system":"sec-edgar","filing":"0001061983-21-000261","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000261/edgardoc.xml","form_type":"4"}},{"id":2503408,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-11-19T23:16:36.000Z","date":"2021-11-19","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.45,"exercise_date":"2018-06-16","expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001061983-21-000261","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000261/edgardoc.xml","form_type":"4"}},{"id":2503407,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T23:16:36.000Z","date":"2021-11-19","kind":"sale","acquired":false,"shares":4032,"price":41.2054,"value":166140.1728,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6765,"source":{"system":"sec-edgar","filing":"0001061983-21-000261","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000261/edgardoc.xml","form_type":"4"}},{"id":2503406,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T23:16:36.000Z","date":"2021-11-19","kind":"exercise","acquired":true,"shares":4032,"price":12.4,"value":49996.8,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":10797,"source":{"system":"sec-edgar","filing":"0001061983-21-000261","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000261/edgardoc.xml","form_type":"4"}},{"id":2503405,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T23:16:36.000Z","date":"2021-11-19","kind":"sale","acquired":false,"shares":20000,"price":41.2054,"value":824108.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6765,"source":{"system":"sec-edgar","filing":"0001061983-21-000261","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000261/edgardoc.xml","form_type":"4"}},{"id":2503404,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T23:16:36.000Z","date":"2021-11-19","kind":"exercise","acquired":true,"shares":20000,"price":14.25,"value":285000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":26765,"source":{"system":"sec-edgar","filing":"0001061983-21-000261","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000261/edgardoc.xml","form_type":"4"}},{"id":2503403,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T23:16:36.000Z","date":"2021-11-19","kind":"sale","acquired":false,"shares":5000,"price":41.2054,"value":206027.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6765,"source":{"system":"sec-edgar","filing":"0001061983-21-000261","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000261/edgardoc.xml","form_type":"4"}},{"id":2503402,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-19T23:16:36.000Z","date":"2021-11-19","kind":"exercise","acquired":true,"shares":5000,"price":9.45,"value":47250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":11765,"source":{"system":"sec-edgar","filing":"0001061983-21-000261","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000261/edgardoc.xml","form_type":"4"}},{"id":2552748,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T23:03:17.000Z","date":"2021-10-01","kind":"grant","acquired":true,"shares":306,"price":36.74,"value":11242.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $36.74, representing the Issuer's closing stock price on October 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,765 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6765,"source":{"system":"sec-edgar","filing":"0001061983-21-000231","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000231/edgardoc.xml","form_type":"4"}},{"id":2628495,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-21T21:14:49.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 10, 2021."}],"balance_after":3035,"derivative":{"exercise_price":10.68,"exercise_date":"2019-06-15","expiration_date":"2029-05-15","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001061983-21-000196","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000196/edgardoc.xml","form_type":"4"}},{"id":2628494,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-21T21:14:49.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":1965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 10, 2021."}],"balance_after":8035,"derivative":{"exercise_price":10.68,"exercise_date":"2019-06-15","expiration_date":"2029-05-15","underlying":"Common Stock","underlying_shares":1965},"source":{"system":"sec-edgar","filing":"0001061983-21-000196","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000196/edgardoc.xml","form_type":"4"}},{"id":2628493,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-21T21:14:49.000Z","date":"2021-07-19","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 10, 2021."}],"balance_after":10000,"derivative":{"exercise_price":10.68,"exercise_date":"2019-06-15","expiration_date":"2029-05-15","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001061983-21-000196","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000196/edgardoc.xml","form_type":"4"}},{"id":2628492,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-21T21:14:49.000Z","date":"2021-07-19","kind":"sale","acquired":false,"shares":5000,"price":28.5,"value":142500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,459 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6459,"source":{"system":"sec-edgar","filing":"0001061983-21-000196","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000196/edgardoc.xml","form_type":"4"}},{"id":2628491,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-21T21:14:49.000Z","date":"2021-07-19","kind":"exercise","acquired":true,"shares":5000,"price":10.68,"value":53400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,459 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":11459,"source":{"system":"sec-edgar","filing":"0001061983-21-000196","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000196/edgardoc.xml","form_type":"4"}},{"id":2628490,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-21T21:14:49.000Z","date":"2021-07-19","kind":"sale","acquired":false,"shares":1965,"price":29.5,"value":57967.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,459 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6459,"source":{"system":"sec-edgar","filing":"0001061983-21-000196","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000196/edgardoc.xml","form_type":"4"}},{"id":2628489,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-21T21:14:49.000Z","date":"2021-07-19","kind":"exercise","acquired":true,"shares":1965,"price":10.68,"value":20986.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,459 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":8424,"source":{"system":"sec-edgar","filing":"0001061983-21-000196","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000196/edgardoc.xml","form_type":"4"}},{"id":2628488,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-21T21:14:49.000Z","date":"2021-07-19","kind":"sale","acquired":false,"shares":5000,"price":29,"value":145000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,459 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6459,"source":{"system":"sec-edgar","filing":"0001061983-21-000196","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000196/edgardoc.xml","form_type":"4"}},{"id":2628487,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-21T21:14:49.000Z","date":"2021-07-19","kind":"exercise","acquired":true,"shares":5000,"price":10.68,"value":53400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,459 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":11459,"source":{"system":"sec-edgar","filing":"0001061983-21-000196","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000196/edgardoc.xml","form_type":"4"}},{"id":2638674,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-08T21:32:11.000Z","date":"2021-07-07","kind":"grant","acquired":true,"shares":63,"price":19.77,"value":1245.51,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $19.77, representing the Issuer's closing stock price on July 7, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,459 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6459,"source":{"system":"sec-edgar","filing":"0001061983-21-000191","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000191/edgardoc.xml","form_type":"4"}},{"id":2645663,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T20:44:34.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":476,"price":20.98,"value":9986.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $20.98, representing the Issuer's closing stock price on July 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 1,396 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6396,"source":{"system":"sec-edgar","filing":"0001061983-21-000171","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000171/edgardoc.xml","form_type":"4"}},{"id":2714992,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-05-14T00:03:15.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options shall vest and become exercisable in 12 equal monthly installments, the first such installment vesting on 06/12/2021 and the last such installment vesting on 05/12/2022."}],"balance_after":10000,"derivative":{"exercise_price":24.32,"exercise_date":"2021-06-12","expiration_date":"2031-05-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001061983-21-000143","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000143/edgardoc.xml","form_type":"4"}},{"id":2714991,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-14T00:03:15.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Comprised of restricted stock units that will vest in full and in one installment on 05/12/2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":5920,"source":{"system":"sec-edgar","filing":"0001061983-21-000143","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000143/edgardoc.xml","form_type":"4"}},{"id":2738782,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-27T21:40:05.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."}],"balance_after":15000,"derivative":{"exercise_price":10.68,"exercise_date":"2020-05-15","expiration_date":"2029-05-15","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001061983-21-000120","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000120/edgardoc.xml","form_type":"4"}},{"id":2738781,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-27T21:40:05.000Z","date":"2021-04-27","kind":"exercise","acquired":false,"shares":4739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."}],"balance_after":0,"derivative":{"exercise_price":10.55,"exercise_date":"2021-01-02","expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":4739},"source":{"system":"sec-edgar","filing":"0001061983-21-000120","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000120/edgardoc.xml","form_type":"4"}},{"id":2738780,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-27T21:40:05.000Z","date":"2021-04-27","kind":"sale","acquired":false,"shares":5000,"price":28,"value":140000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":920,"source":{"system":"sec-edgar","filing":"0001061983-21-000120","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000120/edgardoc.xml","form_type":"4"}},{"id":2738779,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-27T21:40:05.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":5000,"price":10.68,"value":53400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."}],"balance_after":5920,"source":{"system":"sec-edgar","filing":"0001061983-21-000120","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000120/edgardoc.xml","form_type":"4"}},{"id":2738778,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-27T21:40:05.000Z","date":"2021-04-27","kind":"sale","acquired":false,"shares":4739,"price":27.5,"value":130322.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":920,"source":{"system":"sec-edgar","filing":"0001061983-21-000120","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000120/edgardoc.xml","form_type":"4"}},{"id":2738777,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-27T21:40:05.000Z","date":"2021-04-27","kind":"exercise","acquired":true,"shares":4739,"price":10.55,"value":49996.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."}],"balance_after":5659,"source":{"system":"sec-edgar","filing":"0001061983-21-000120","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000120/edgardoc.xml","form_type":"4"}},{"id":2738776,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-27T20:47:30.000Z","date":"2021-04-26","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."}],"balance_after":5000,"derivative":{"exercise_price":9.45,"exercise_date":"2019-05-16","expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001061983-21-000118","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000118/edgardoc.xml","form_type":"4"}},{"id":2738775,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-27T20:47:30.000Z","date":"2021-04-26","kind":"sale","acquired":false,"shares":5000,"price":27,"value":135000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":920,"source":{"system":"sec-edgar","filing":"0001061983-21-000118","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000118/edgardoc.xml","form_type":"4"}},{"id":2738774,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-27T20:47:30.000Z","date":"2021-04-26","kind":"exercise","acquired":true,"shares":5000,"price":9.45,"value":47250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."}],"balance_after":5920,"source":{"system":"sec-edgar","filing":"0001061983-21-000118","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000118/edgardoc.xml","form_type":"4"}},{"id":2741133,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-23T21:32:58.000Z","date":"2021-04-23","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."}],"balance_after":10000,"derivative":{"exercise_price":9.45,"exercise_date":"2019-05-16","expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001061983-21-000116","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000116/edgardoc.xml","form_type":"4"}},{"id":2741132,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-23T21:32:58.000Z","date":"2021-04-23","kind":"sale","acquired":false,"shares":5000,"price":26.5,"value":132500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":920,"source":{"system":"sec-edgar","filing":"0001061983-21-000116","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000116/edgardoc.xml","form_type":"4"}},{"id":2741131,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-23T21:32:58.000Z","date":"2021-04-23","kind":"exercise","acquired":true,"shares":5000,"price":9.45,"value":47250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":5920,"source":{"system":"sec-edgar","filing":"0001061983-21-000116","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000116/edgardoc.xml","form_type":"4"}},{"id":2748795,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-15T22:55:34.000Z","date":"2021-04-15","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."}],"balance_after":15000,"derivative":{"exercise_price":9.45,"exercise_date":"2018-06-16","expiration_date":"2028-05-16","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001061983-21-000113","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000113/edgardoc.xml","form_type":"4"}},{"id":2748794,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-15T22:55:34.000Z","date":"2021-04-15","kind":"exercise","acquired":false,"shares":5714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."}],"balance_after":0,"derivative":{"exercise_price":8.75,"exercise_date":"2018-02-02","expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":5714},"source":{"system":"sec-edgar","filing":"0001061983-21-000113","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000113/edgardoc.xml","form_type":"4"}},{"id":2748793,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-15T22:55:34.000Z","date":"2021-04-15","kind":"sale","acquired":false,"shares":5714,"price":25,"value":142850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":920,"source":{"system":"sec-edgar","filing":"0001061983-21-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000113/edgardoc.xml","form_type":"4"}},{"id":2748792,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-15T22:55:34.000Z","date":"2021-04-15","kind":"exercise","acquired":true,"shares":5714,"price":8.75,"value":49997.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":6634,"source":{"system":"sec-edgar","filing":"0001061983-21-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000113/edgardoc.xml","form_type":"4"}},{"id":2748791,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-15T22:55:34.000Z","date":"2021-04-15","kind":"sale","acquired":false,"shares":5000,"price":25.5,"value":127500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":920,"source":{"system":"sec-edgar","filing":"0001061983-21-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000113/edgardoc.xml","form_type":"4"}},{"id":2748790,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-15T22:55:34.000Z","date":"2021-04-15","kind":"exercise","acquired":true,"shares":5000,"price":9.45,"value":47250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":5920,"source":{"system":"sec-edgar","filing":"0001061983-21-000113","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000113/edgardoc.xml","form_type":"4"}},{"id":2751366,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"exercise","acquired":false,"shares":4375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."}],"balance_after":0,"derivative":{"exercise_price":10,"exercise_date":"2016-02-04","expiration_date":"2026-01-04","underlying":"Common Stock","underlying_shares":4375},"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751365,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."}],"balance_after":0,"derivative":{"exercise_price":7.61,"exercise_date":"2016-06-18","expiration_date":"2026-05-18","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751364,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."}],"balance_after":5000,"derivative":{"exercise_price":7.61,"exercise_date":"2016-06-18","expiration_date":"2026-05-18","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751363,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."}],"balance_after":10000,"derivative":{"exercise_price":7.61,"exercise_date":"2016-06-18","expiration_date":"2026-05-18","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751362,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."}],"balance_after":15000,"derivative":{"exercise_price":7.61,"exercise_date":"2016-06-18","expiration_date":"2026-05-18","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751361,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"exercise","acquired":false,"shares":3207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."}],"balance_after":0,"derivative":{"exercise_price":6.82,"exercise_date":"2019-02-01","expiration_date":"2029-01-02","underlying":"Common Stock","underlying_shares":3207},"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751360,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"sale","acquired":false,"shares":4375,"price":24.5,"value":107187.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":920,"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751359,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"exercise","acquired":true,"shares":4375,"price":10,"value":43750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":5295,"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751358,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"sale","acquired":false,"shares":5000,"price":23.7899,"value":118949.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":920,"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751357,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"exercise","acquired":true,"shares":5000,"price":7.61,"value":38050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":5920,"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751356,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"sale","acquired":false,"shares":5000,"price":23.7885,"value":118942.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":920,"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751355,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"exercise","acquired":true,"shares":5000,"price":7.61,"value":38050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":5920,"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751354,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"sale","acquired":false,"shares":5000,"price":23.7989,"value":118994.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":920,"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751353,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"exercise","acquired":true,"shares":5000,"price":7.61,"value":38050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":5920,"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751352,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"sale","acquired":false,"shares":5000,"price":23.7896,"value":118948.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":920,"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751351,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"exercise","acquired":true,"shares":5000,"price":7.61,"value":38050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":5920,"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751350,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"sale","acquired":false,"shares":3207,"price":24,"value":76968.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":920,"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2751349,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-12T20:21:38.000Z","date":"2021-04-09","kind":"exercise","acquired":true,"shares":3207,"price":6.82,"value":21871.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 10, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":4127,"source":{"system":"sec-edgar","filing":"0001061983-21-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000109/edgardoc.xml","form_type":"4"}},{"id":2758707,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-05T21:47:58.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":409,"price":24.44,"value":9995.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $24.44, representing the Issuer's closing stock price on April 1, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 920 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":920,"source":{"system":"sec-edgar","filing":"0001061983-21-000099","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000099/edgardoc.xml","form_type":"4"}},{"id":2922130,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T23:17:54.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":511,"price":19.56,"value":9995.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares issued at Reporting Person's election pursuant to Issuer's stock in lieu of cash for all or part of directors' annual base retainer program.  Shares are full vested from the moment of grant.  Shares issued at per share price of $19.56, representing the Issuer's closing stock price on January 4, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount includes 511 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program."}],"balance_after":511,"source":{"system":"sec-edgar","filing":"0001061983-21-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198321000016/edgardoc.xml","form_type":"4"}},{"id":3008038,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-13T15:42:56.000Z","date":"2020-10-12","kind":"disposition_to_issuer","acquired":false,"shares":26400,"price":2.01,"value":53064.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided for vesting of the shares on April 13, 2021, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $53,064.00, representing the difference between the exercise price of the option and the acquisition price of $18.15."}],"balance_after":0,"derivative":{"exercise_price":16.14,"expiration_date":"2030-04-12","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0001209191-20-054610","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1243004/000120919120054610/doc4.xml","form_type":"4"}},{"id":3008037,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-10-13T15:42:56.000Z","date":"2020-10-12","kind":"disposition_to_issuer","acquired":false,"shares":52837,"price":5.94,"value":313851.78,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, which provided that 25% of the shares would vest in equal yearly installments over four years on the anniversary of March 13, 2017, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $313,851.78, representing the difference between the exercise price of the option and the acquisition price of $18.15."}],"balance_after":0,"derivative":{"exercise_price":12.21,"expiration_date":"2027-06-04","underlying":"Common Stock","underlying_shares":52837},"source":{"system":"sec-edgar","filing":"0001209191-20-054610","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1243004/000120919120054610/doc4.xml","form_type":"4"}},{"id":3013930,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-10-06T01:11:58.000Z","date":"2020-10-05","kind":"exercise","acquired":false,"shares":5936,"price":2.95,"value":17511.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on May 13, 2020."}],"balance_after":0,"derivative":{"exercise_price":7.37,"exercise_date":"2015-02-02","expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":5936},"source":{"system":"sec-edgar","filing":"0001061983-20-000165","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000165/edgardoc.xml","form_type":"4"}},{"id":3013929,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T01:11:58.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":5936,"price":30,"value":178080.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on May 13, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001061983-20-000165","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000165/edgardoc.xml","form_type":"4"}},{"id":3013928,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T01:11:58.000Z","date":"2020-10-05","kind":"exercise","acquired":true,"shares":5936,"price":7.37,"value":43748.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on May 13, 2020."}],"balance_after":5936,"source":{"system":"sec-edgar","filing":"0001061983-20-000165","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000165/edgardoc.xml","form_type":"4"}},{"id":3080923,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-07-17T21:14:57.000Z","date":"2020-07-15","kind":"exercise","acquired":false,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on May 13, 2020."}],"balance_after":0,"derivative":{"exercise_price":6.21,"exercise_date":"2015-06-20","expiration_date":"2025-05-20","underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001061983-20-000130","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000130/edgardoc.xml","form_type":"4"}},{"id":3080922,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-17T21:14:57.000Z","date":"2020-07-15","kind":"sale","acquired":false,"shares":6667,"price":29,"value":193343.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on May 13, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001061983-20-000130","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000130/edgardoc.xml","form_type":"4"}},{"id":3080921,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-17T21:14:57.000Z","date":"2020-07-15","kind":"exercise","acquired":true,"shares":6667,"price":6.21,"value":41402.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on May 13, 2020."}],"balance_after":6667,"source":{"system":"sec-edgar","filing":"0001061983-20-000130","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000130/edgardoc.xml","form_type":"4"}},{"id":3084496,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-07-13T21:34:03.000Z","date":"2020-07-10","kind":"exercise","acquired":false,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on May 13, 2020."}],"balance_after":6667,"derivative":{"exercise_price":6.21,"exercise_date":"2015-06-20","expiration_date":"2025-05-20","underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001061983-20-000127","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000127/edgardoc.xml","form_type":"4"}},{"id":3084495,"issuer":{"id":3528,"kind":"organization","name":"CYTOKINETICS INC","symbol":"CYTK"},"owners":[{"id":95598,"kind":"person","name":"SMITH SANDFORD D","position":1,"cik":"0001243004","reported_name":"SMITH SANDFORD D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-13T21:34:03.000Z","date":"2020-07-10","kind":"sale","acquired":false,"shares":6667,"price":28,"value":186676.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on May 13, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001061983-20-000127","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1061983/000106198320000127/edgardoc.xml","form_type":"4"}}],"next_cursor":"2020-07-13T21:34:03.000000Z,3084495"}